Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Agency
- Veterans Integrated Service Network 15 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Hines, Illinois 60141, United States
- Points of contact
-
- Jennifer Coleman jennifer.coleman4@va.gov (913) 758-9934
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 issued a Request for Quote for Ciprofloxacin 400 MG/200ML-D5W intravenous solution with an offer due date of July 8, 2026, at 3:00 PM CDT; this is a full and open competition (reclassified from small business set-aside via Amendment 0002 issued July 2, 2026), and clause 52.222-90 applies.
The VA seeks quotes for 3,062 boxes of 24 bags per carton (NDC 25021-0114-87) for delivery to the Emergency Pharmacy Services facility at VA Hines, Illinois (5000 S. 5th Ave, Bldg. 37, Dock #14, Hines, IL 60141). The base contract covers a single delivery with four one-year option periods; option year price increases may not exceed 3 percent annually. Offerors must submit pricing on the provided Excel spreadsheet, include an SF 1449 cover page, provide a valid state wholesale distributor license, and submit a TAA Certificate. Products must have FDA therapeutic equivalence code "A," expiration dates no less than 16–18 months from delivery, and GS1-128 or HIBCC bar code labeling at Quality Grade C or better. DSCSA compliance (Transaction History, Transaction Information, and Transaction Statement documentation) is required. Vendor contact is Rachel Joseph, Pharm.D. (Rachel.Joseph@va.gov) for delivery coordination; Jennifer Coleman (Jennifer.Coleman4@va.gov) receives supporting documents. Acknowledgment of Amendment 0002 is mandatory prior to submission.
Notice text
CMOP Pharmaceutical
The solicitation has been deemed Full and Open. The Clause 52.222-90 has been added to the solicitation and it has been extended until July 8, 2026.
Attachments
| File | Type | Posted |
|---|---|---|
| MS02 - RFQ - Q0112 0002 - RFQ MOD FULL.pdf | ||
| S02 - Pric. Schedule Q0112 - EPS CIPRO - EXT.xlsx | XLSX spreadsheet | |
| MS02 - RFQ - Q0112 0002 - RFQ MOD ONLY.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--sagent - ciprofloxacin 400 MG/200ML-D5W - base+4 | Award Notice | |
| Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765 | Special Notice | |
| Extending Close Date - Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765 | Special Notice | |
| Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765 | Solicitation | |
| Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765 | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity